THX-110

· Neurothera Labs Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for THX-110, covering 2018-08-24 to 2018-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome [Phase 2]